Mackenzie Financial’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,955
Closed -$189K 1722
2025
Q1
$189K Sell
13,955
-775,922
-98% -$12.9M ﹤0.01% 1530
2024
Q4
$13.3M Sell
789,877
-18,177
-2% -$354K 0.02% 415
2024
Q3
$16.4M Sell
808,054
-69,192
-8% -$1.41M 0.02% 375
2024
Q2
$19.8M Buy
877,246
+123,418
+16% +$3.23M 0.03% 338
2024
Q1
$19.8M Buy
753,828
+226,980
+43% +$6.47M 0.03% 332
2023
Q4
$16.6M Buy
526,848
+95,814
+22% +$2.6M 0.03% 364
2023
Q3
$11.6M Sell
431,034
-121,072
-22% -$4.16M 0.02% 404
2023
Q2
$20.6M Sell
552,106
-20,313
-4% -$620K 0.03% 328
2023
Q1
$17.1M Sell
572,419
-27,500
-5% -$906K 0.03% 356
2022
Q4
$18.4M Buy
599,919
+15,223
+3% +$457K 0.03% 323
2022
Q3
$14.4M Sell
584,696
-179,942
-24% -$5.94M 0.02% 362
2022
Q2
$24.5M Sell
764,638
-19,491
-2% -$717K 0.04% 294
2022
Q1
$24.7M Sell
784,129
-96,838
-11% -$3.03M 0.03% 320
2021
Q4
$29.6M Buy
880,967
+108,585
+14% +$3.38M 0.04% 301
2021
Q3
$22.4M Buy
772,382
+25,939
+3% +$840K 0.03% 319
2021
Q2
$26M Buy
746,443
+354,983
+91% +$11.8M 0.04% 301
2021
Q1
$10.9M Buy
+391,460
New +$10.4M 0.02% 407
2020
Q3
Sell
-12,134
Closed -$186K 998
2020
Q2
$186K Sell
12,134
-11,400
-48% -$144K ﹤0.01% 953
2020
Q1
$209K Sell
23,534
-1,900
-7% -$27.4K ﹤0.01% 972
2019
Q4
$460K Buy
+25,434
New +$422K ﹤0.01% 870
2018
Q2
Sell
-45,562
Closed -$2.22M 1009
2018
Q1
$2.22M Sell
45,562
-570
-1% -$28.5K 0.01% 547
2017
Q4
$2.31M Buy
+46,132
New +$2.42M 0.01% 518

Other funds holding CC

Mackenzie Financial's CC Position: Q2 2025 in Review

Mackenzie Financial sold out of Chemours (CC) in Q2 2025, closing a stake of 13,955 shares — an estimated $189K sold.

Mackenzie Financial first reported a position in CC in Q4 2017 and held it in 22 quarters. The position peaked at $29.6M in Q4 2021. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

  • Mackenzie Financial reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
  • Mackenzie Financial sold 13,955 Chemours shares in Q2 2025, an estimated $189K.
  • Mackenzie Financial first reported a position in Chemours in Q4 2017 and held it in 22 quarters.
  • Mackenzie Financial's Chemours position peaked at $29.6M in Q4 2021.
  • 434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Mackenzie Financial's 13F filing for Q2 2025, filed 13 Aug 2025.